Insights into muscle atrophy and recovery pathway based on genetic models

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 9, Issue 4, 2006, Pages 395-402

  Stein, T Peter ^a   Bolster, Douglas R ^b  

^a UMDNJ School of Osteopathic Medicine   (United States)

^b UNIVERSITIES SPACE RESEARCH ASSOCIATION   (United States)

Author keywords

Expression analysis; Muscle atrophy; Recovery pathways; Reductive remodeling pathways

Indexed keywords

AMINO ACID; ANABOLIC AGENT; BOWMAN BIRK INHIBITOR; CLENBUTEROL; CREATINE; ICOSAPENTAENOIC ACID; MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MYO 029; MUSCLE PROTEIN; TESTOSTERONE; UNCLASSIFIED DRUG;

AGING; BECKER MUSCULAR DYSTROPHY; BED REST; CLINICAL FEATURE; CLINICAL TRIAL; CONVALESCENCE; DIET SUPPLEMENTATION; ENERGY RESOURCE; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE EXPRESSION REGULATION; GENETIC MODEL; HEALTH STATUS; HUMAN; IMMOBILIZATION; INJURY; LIMB GIRDLE MUSCULAR DYSTROPHY; MUSCLE ATROPHY; MUSCLE EXERCISE; NONHUMAN; NUTRITIONAL SUPPORT; PHENOTYPE; REVIEW; RISK ASSESSMENT; SEPSIS;

BED REST; EXERCISE; HUMANS; MODELS, GENETIC; MUSCULAR ATROPHY; NUTRITIONAL SUPPORT;

EID: 33746209093     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/01.mco.0000232899.51544.69     Document Type: Review

References (44)

1. Fitts RH, Riley DR, Widrick JJ. Functional and structural adaptations of skeletal muscle to microgravity. J Exp Biol 2001; 204:3201-3208.
2. Fluck M, Schmutz S, Wittwer M, et al. Transcriptional reprogramming during reloading of atrophied rat soleus muscle. Am J Physiol Regul lntegr Comp Physiol 2005; 289:R4-R14. Begins to identify the sequence of steps in the remodeling process.
3. Sandri M, Sandri C, Gilbert A, et al. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 2004; 117:399-412.
4. Stitt TN, Drujan D, Clarke BA, et al. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 2004; 14:395-403.
5. Kedar V, McDonough H, Arya R, et al. Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I. Proc Natl Acad Sci U S A 2004; 101:18135-18140.
6. Pizon V, Iakovenko A, van der Ven PFM, et al. Transient association of titin and myosin with microtubules in nascent myofibrils directed by the MURF2 RING-finger protein. J Cell Sci 2002; 115:4469-4482.
7. Lange S, Xiang F, Yakovenko A, et al. The kinase domain of titin controls muscle gene expression and protein turnover. Science 2005; 308:1599-1603. A truly elegant and comprehensive study. Describes the steps between muscle tension and protein turnover and how they relate to a human myopathy.
8. Acharyya S, Butchbach MER, Sahenk Z, et al. Dystrophin glycoprotein complex dysfunction: a regulatory link between muscular dystrophy and cancer cachexia. Cancer Cell 2005; 8:421-432.
9. Becque MD, Lochmann JD, Melrose DR. Effects of oral creatine supplementation on muscular strength and body composition. Med Sci Sports Exerc 2000; 32:654-658.
10. Hardie DG, Carling D. The AMP-activated protein kinase: fuel gauge of the mammalian cell? Eur J Biochem 1997; 246:259-273.
11. Hilder TL, Baer LA, Fuller PM, et al. Insulin-independent pathways mediating glucose uptake in hindlimb-suspended skeletal muscle. J Appl Physiol 2005; 99:2181-2188.
12. Horman S, Browne GJ, Krause U, et al. Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis. Curr Biol 2002; 12:1419-1423.
13. Ingwall JS, Morales MF, Stockdale FE. Creatine and the control of myosin synthesis in differentiating skeletal muscle. Proc Natl Acad Sci U S A 1972; 69:2250-2253.
14. Lecker SH, Jagoe RT, Gilbert A, et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J 2004; 18:39-51.
15. Bodine SC, Latres E, Baumhueter S, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001; 294:1704-1708.
16. Mitch WE, Bailey JL, Wang X, et al. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Am J Physiol Cell Physiol 1999; 276:C1132-C1138.
17. Fitts RH, Riley DR, Widrick JJ. Physiology of a microgravity environment invited review: microgravity and skeletal muscle. J Appl Physiol 2000; 89:823-839.
18. Stein TP, Wade CE. Metabolic consequences of disuse atrophy. J Nutr 2005; 135:1824-1830.
19. Stein TP, Schluter MD, Galante AT, et al. Effect of hind limb muscle unloading on liver metabolism of rats. J Nutr Biochem 2005; 16:9-16.
20. Stein TP, Schluter MD, Galante AT, et al. Energy metabolism pathways in rat muscle under conditions of simulated microgravity. Nutr Biochem 2002; 13:471-478.
21. Stevenson EJ, Giresi PG, Koncarevic A, et al. Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle. J Physiol 2003; 551:33-48.
22. Hardie DG, Sakamoto K. AMPK: a key sensor of fuel and energy status in skeletal muscle. Physiology 2006; 21:48-60. An excellent review of the role and importance of AMPK in regulating muscle energy metabolism and how it may relate to muscle work capacity.
23. Ponticos M, Lu QL, Morgan JE, et al. Dual regulation of the AMP-activated protein kinase provides a novel mechanism for the control of creatine kinase in skeletal muscle. EMBO J 1998; 17:1688-1699.
24. Booth FW. Physiologic and biochemical effects of immobilization on muscle. Clin Orthop 1987; 219:15-20.
25. Hespel P, Eijnde BO, Derave W, et al. Creatine supplementation: exploring the role of the creatine kinase/phosphocreatine system in human muscle. Can J Appl Physiol 2001; 26:S79-S102.
26. Bolster DR, Crozier SJ, Kimball SR, Jefferson LS. AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling. J Biol Chem 2002; 277:23977-23980.
27. Inoki K, Zhu T, Guan K-L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003; 115:577-590.
28. Cheng SWY, Fryer LGD, Carling D, Shepherd PR. Thr2446 is a novel mammalian target of rapamycin (mTOR) phosphorylation site regulated by nutrient status. J Biol Chem 2004; 279:15719-15722.
29. Momken I, Lechene P, Koulmann N, et al. Impaired voluntary running capacity of creatine kinase-deficient mice. J Physiol (Lond) 2005; 565:951-964.
30. Koopman R, Manders RJF, Zorenc AHG, et al. A single session of resistance exercise enhances insulin sensitivity for at least 24 h in healthy men. Eur J Appl Physiol 2005; 94:180-187. An attempt to address the question of how much and for how the benefits of exercise last.
31. Jubrias SA, Esselman PC, Price LB, et al. Large energetic adaptations of elderly muscle to resistance and endurance training. J Appl Physiol 2001; 90:1663-1670.
32. Yasuda N, Glover EI, Phillips SM, et al. Sex-based differences in skeletal muscle function and morphology with short-term limb immobilization. J Appl Physiol 2005; 99:1085-1092. Despite similar relative changes in lean body mass and muscle cross-sectional area during limb immobilization, females experienced greater reductions in distinct indices of strength. These results suggest a possible intrinsic neuromuscular alteration in females with muscle atrophy. More information on gender differences is required as this is a major unresolved problem.
33. Snow RJ, Murphy RM. Factors influencing creatine loading into human skeletal muscle. Exerc Sport Sci Rev 2003; 31:154-158.
34. Jacobs PL, Mahoney ET, Cohn KA, et al. Oral creatine supplementation enhances upper extremity work capacity in persons with cervical-level spinal cord injury. Arch Phys Med Rehabil 2002; 83:19-23.
35. Louis M, Raymackers JM, Debaix H, et al. Effect of creatine supplementation on skeletal muscle of mdx mice. Muscle Nerve 2004; 29:687-692.
36. Tarnopolsky MA, Mahoney DJ, Vajsar J, et al. Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy. Neurology 2004; 62:1771-1777.
37. Volek JS, Duncan ND, Mazzettis SA, et al. Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. Med Sci Sports Exerc 1999; 31:1147-1156.
38. Eijnde BO, Van Leemputte M, Goris M, et al. Effects of creatine supplementation and exercise training on fitness in men 55-75 yr old. J Appl Physiol 2003; 95:818-828.
39. Louis M, Poortmans JR, Francaux M, et al. No effect of creatine supplementation on human myofibrillar and sarcoplasmic protein synthesis after resistance exercise. Am J Physiol Endocrinol Metab 2003; 285:E1089-E1094.
40. Parise G, Mihic S, MacLennan D, et al. Effects of acute creatine monohydrate supplementation on leucine kinetics and mixed-muscle protein synthesis. J Appl Physiol 2001; 91:1041-1047.
41. Willoughby DS, Rosene J. Effects of oral creatine and resistance training on myosin heavy chain expression. Med Sci Sports Exerc 2001; 33:1674-1681.
42. Visser M, Kritchevsky SB, Newman AB, et al. Lower serum albumin concentration and change in muscle mass: the Health, Aging and Body Composition Study. Am J Clin Nutr 2005; 82:531-537. Serum albumin levels are related to both nutritional status and skeletal muscle mass. An intriguing observation.
43. Morris CA, Morris LD, Kennedy AR, Sweeney HL. Attenuation of skeletal muscle atrophy via protease inhibition. J Appl Physiol 2005; 99:1719-1727. This study shows the potential for a targeted biochemical intervention. Muscle atrophy induced with hindlimb unloading was significantly reduced in animals fed a soybean-derived protease inhibitor that is nontoxic and orally bioavailable.
44. Smith HJ, Greenberg NA, Tisdale MJ. Effect of eicosapentaenoic acid, protein and amino acids on protein synthesis and degradation in skeletal muscle of cachectic mice. Br J Cancer 2004; 91:408-412.